— Avid Bioservices (NASDAQ: CDMO) reported a loss of $0.## per share for its third quarter of 2020 vs. expected loss of $0.04 per share.
— Revenue was $13.6 million vs. $15.42 million expected.
— As of January 31, 2020, revenue backlog was approximately $58 million.
— For fiscal 2020, the company reduced its revenue outlook to a range of $55 million to $59 million from the previously issued guidance of $64 million to $67 million.
— Avid Bioservices stated that the temporary production interruption resulted in lower revenue and profits for the third quarter. This interruption is also expected to impact revenues and profits for the fourth quarter of fiscal 2020.
— CDMO shares plummeted more than 15% during the after-hours.
Most Popular
Infographic: How UnitedHealth Group (UNH) performed in Q1 2024
UnitedHealth Group (NYSE: UNH) reported its first quarter 2024 earnings results today. Revenues increased 9% year-over-year to $99.8 billion. Net loss attributable to UnitedHealth Group common shareholders was $1.4 billion,
MS Infographic: Morgan Stanley reports higher revenue and profit for Q1 2024
Banking giant Morgan Stanley (NYSE: MS) announced financial results for the first quarter of 2024, reporting an increase in revenues and net profit. Net income applicable to shareholders was $3.41
BAC Earnings: All you need to know about Bank of America’s Q1 2024 earnings results
Bank of America (NYSE: BAC) reported its first quarter 2024 earnings results today. Total revenue decreased 2% year-over-year to $25.8 billion. Net income was $6.7 billion, or $0.76 per share,
Comments
Comments are closed.